GME vs NMRA · P/E 16, rev $3.63B vs $283.5M cap
GameStop Corp. (GME) versus Neumora Therapeutics, Inc. (NMRA) — a side-by-side from cached financials, not a winner call.
GameStop Corp. (GME) is a specialty retail company listed on US. It is led by Ryan Cohen.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Latest reported GME revenue for 2026-01-31 was $3.63B. Net income was $418.4M. Revenue was down 5.1% from 2025-02-01 to 2026-01-31. GME currently screens at market cap $9.78B and trailing P/E 16.3.
NMRA does not have a complete income-statement cache yet.
GME currently screens at market cap $9.78B and trailing P/E 16.3. NMRA currently screens at market cap $283.5M.
Not investment advice. Open the GME and NMRA stock pages for the full models.
Not investment advice.